BrightGene Bio-Medical Technology Co

BrightGene Bio-Medical Technology Co Share Buybacks

Share Buybacks of BrightGene Bio-Medical Technology Co (688166.SS) as of Nov 22, 2026.

Share Buybacks

-CNY

Last updated:

Share Buybacks of BrightGene Bio-Medical Technology Co is 2026 - CNY. Share Buybacks of BrightGene Bio-Medical Technology Co was 2025 0.00 CNY. It decreases by % lower compared to the previous year.

The BrightGene Bio-Medical Technology Co Share Buybacks history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Share Buybacks
Date
Share Buybacks
Jan 1, 2017
0.00 CNY
Jan 1, 2018
0.00 CNY
Jan 1, 2019
0.00 CNY
Jan 1, 2020
0.00 CNY
Jan 1, 2021
0.00 CNY
Jan 1, 2022
0.00 CNY
Jan 1, 2023
0.00 CNY
Jan 1, 2024
0.00 CNY
The BrightGene Bio-Medical Technology Co Share Buybacks history
YEARShare BuybacksYoY
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BrightGene Bio-Medical Technology Co Stock analysis

What does BrightGene Bio-Medical Technology Co do? BrightGene Bio-Medical Technology Co., Ltd. generates revenue by researching, developing, and manufacturing biopharmaceuticals, medicines, and special generic active pharmaceutical ingredients and finished dosage forms. The company's product portfolio centers on antifungal, antiviral, and immunosuppressive APIs, alongside other APIs and preparations. Its generic drug offerings specifically include entecavir, caspofungin, micafungin, posaconazole, everolimus, and fondaparinux sodium. The firm sells these products to customers in both domestic and overseas markets. By leveraging its capabilities in producing essential active pharmaceutical ingredients and finished dosage forms, the company serves the broader pharmaceutical sector through its established manufacturing and research operations. BrightGene Bio-Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BrightGene Bio-Medical Technology Co stock

On Eulerpool you can find the complete historical development of Share Buybacks BrightGene Bio-Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

Share buybacks represent the cash spent repurchasing the company's own shares. Buybacks reduce shares outstanding and can increase EPS.

Share Buybacks's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Share Buybacks's BrightGene Bio-Medical Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — BrightGene Bio-Medical Technology Co

All Key Metrics — BrightGene Bio-Medical Technology Co